Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
News Releases

Fasken Martineau advises Omega Laboratories on its sale to Sagent Pharmaceuticals

Reading Time 2 minute read
Fasken Martineau advised on a C$95m pharmaceutical industry acquisition transaction.

Montréal (Canada) - Fasken Martineau, a leading international business law and litigation firm, announced today that it advised Omega Laboratories on the sale of the business to Sagent Pharmaceuticals. The transaction was worth C$95 million.

Established in Montréal, Omega Laboratories offers the pharmaceutical industry a full range of specialized products and services. One of its specialties is manufacturing a wide range of injectable and non-injectable solutions. Sagent Pharmaceuticals is an American pharmaceutical products company based in Illinois.

"We are proud to have accompanied Omega Laboratories throughout this transaction. Our team members contributed their expertise to help ensure this transaction was a success, allowing our client to join Sagent Pharmaceuticals' large multinational team, maintain its base and keep jobs in Québec, and see its plans and strategies of expanding internationally become a reality more quickly," said Patrice Vachon, partner at Fasken Martineau and lead lawyer on this transaction.

The Fasken Martineau team that acted as legal counsel for Omega Laboratories was led by Patrice Vachon and consisted of Marie-Eve Clavet, Kiran Singh, Anabel Quessy, Joëlle Simard, Pierre-Olivier Charlebois, Emilie Bundock and Alain Ranger.

About Fasken Martineau

Fasken Martineau is a leading international business law and litigation firm. With more than 770 lawyers, the firm has offices in Vancouver, Calgary, Toronto, Ottawa, Montréal, Québec City, London, Paris and Johannesburg. For additional information, please visit the firm's website at


    Receive email updates from our team